<SEC-DOCUMENT>0001140361-22-026785.txt : 20220725
<SEC-HEADER>0001140361-22-026785.hdr.sgml : 20220725
<ACCEPTANCE-DATETIME>20220725060312
ACCESSION NUMBER:		0001140361-22-026785
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20220725
FILED AS OF DATE:		20220725
DATE AS OF CHANGE:		20220725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IPERIONX Ltd
		CENTRAL INDEX KEY:			0001898601
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS METAL ORES [1090]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41338
		FILM NUMBER:		221100933

	BUSINESS ADDRESS:	
		STREET 1:		129 W TRADE STREET
		STREET 2:		SUITE 1405
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202
		BUSINESS PHONE:		7045783217

	MAIL ADDRESS:	
		STREET 1:		129 W TRADE STREET
		STREET 2:		SUITE 1405
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Hyperion Metals Ltd
		DATE OF NAME CHANGE:	20211210
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>brhc10039923_6-k.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, LLC
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div id="DSPFPageHeader">
        <div><br>
        </div>
      </div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center;"></div>
      <div style="font-weight: 400;"> <br>
      </div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 6-K</div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">REPORT&#160;OF FOREIGN PRIVATE ISSUER</div>
      <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 or 15d-16 of the</div>
      <div style="text-align: center; font-weight: bold;">Securities Exchange Act of 1934</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Date: July 25, 2022</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Commission File Number:</font><font style="font-size: 10pt;">&#160;<font style="font-weight: bold;">001-41338</font></font></div>
      <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-weight: bold;"> <br>
          </font></font></div>
      <div>
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center;"></div>
      <div style="font-weight: 400;"> <br>
      </div>
      <div style="text-align: center; font-size: 24pt; font-weight: bold;">IperionX Limited</div>
      <div style="text-align: center; font-weight: bold;">(Translation of registrant&#8217;s name into English)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">129 W Trade Street, Suite 1405</div>
      <div style="text-align: center; font-weight: bold;">Charlotte, North Carolina</div>
      <div style="text-align: center; font-weight: bold;">(Address of principal executive offices)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center;"></div>
      <div style="text-indent: 36pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
      <div><br>
      </div>
      <div style="text-indent: 108pt; font-size: 14pt;"><font style="font-size: 10pt;">Form 20-F </font><font style="font-size: 10pt; font-family: 'Segoe UI Symbol',sans-serif;">&#9746;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;Form 40-F </font><font style="font-size: 10pt; font-family: 'Segoe UI Symbol',sans-serif;">&#9744;</font></div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-size: 14pt;"><font style="font-size: 10pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper
          as permitted by Regulation S-T Rule 101(b)(1): </font><font style="font-size: 10pt; font-family: 'Segoe UI Symbol',sans-serif;">&#9744;</font></div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-size: 14pt;"><font style="font-size: 10pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper
          as permitted by Regulation S-T Rule 101(b)(7): </font><font style="font-size: 10pt; font-family: 'Segoe UI Symbol',sans-serif;">&#9744;</font></div>
      <div style="text-indent: 36pt; font-size: 14pt;"><font style="font-size: 10pt; font-family: 'Segoe UI Symbol',sans-serif;"> <br>
        </font></div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageFooter">
          <div><br>
          </div>
        </div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader">
          <div><br>
          </div>
        </div>
      </div>
      <div style="text-align: center; font-weight: bold;">EXHIBIT INDEX</div>
      <div><br>
      </div>
      <div>The following exhibits are filed as part of this Form 6-K:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z04ece2053d734c849091702725f17b7b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 9.82%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;">Exhibit</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="width: 89%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.82%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="vertical-align: bottom;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.82%; vertical-align: top;">
              <div><a href="brhc10039923_ex99-1.htm">99.1</a></div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 89%; vertical-align: top;">
              <div>Press Release, dated July 25, 2022</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageFooter">
          <div><br>
          </div>
        </div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader">
          <div><br>
          </div>
        </div>
      </div>
      <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
      <div style="text-align: center;">&#160;&#160;</div>
      <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
        thereunto duly authorized.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z353f8f4b15e446d992ccc54c80a6159f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 52.96%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="width: 47.04%; vertical-align: bottom;">
              <div>IPERIONX LIMITED</div>
            </td>
          </tr>
          <tr>
            <td style="width: 52.96%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="width: 47.04%; vertical-align: bottom;">
              <div>(registrant)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 52.96%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="width: 47.04%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 52.96%; vertical-align: bottom;">
              <div>Date: July 25, 2022</div>
            </td>
            <td style="width: 47.04%; vertical-align: bottom;">
              <div>By: &#160;<u>/s/ Anastasios Arima</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 52.96%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="width: 47.04%; vertical-align: bottom;">
              <div>Name: Anastasios Arima</div>
            </td>
          </tr>
          <tr>
            <td style="width: 52.96%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="width: 47.04%; vertical-align: bottom;">
              <div>Title:&#160;&#160; Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div id="DSPFPageFooter">
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>brhc10039923_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, LLC
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div> <br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" border="0" id="z6e85446087324ab0b471dbf225059648" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td colspan="1" rowspan="3" style="width: 50.00%;"><img src="image00001.jpg"></td>
          <td style="width: 50.00%;">
            <div style="text-align: right; color: #002554; font-size: 8pt;"><font style="font-weight: bold;">PRESS RELEASE</font> | NASDAQ: IPX | ASX: IPX</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50.00%;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50.00%;">
            <div style="text-align: right; color: rgb(0, 37, 84); font-size: 8pt; font-style: italic;">July 25, 2022</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; color: rgb(0, 37, 84); font-style: normal; font-weight: bold;">IPERIONX AND OAK RIDGE NATIONAL LABORATORY TECHNICAL COLLABORATION</div>
      <div style="color: rgb(0, 0, 0); font-style: normal; font-weight: 400;"> <font style="font-style: normal; color: rgb(146, 146, 146);"><br>
        </font></div>
      <div style="color: rgb(0, 0, 0); font-style: normal; font-weight: 400;"><font style="font-style: normal; color: rgb(146, 146, 146);"> </font>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z68033f9592174aaeb03ca5cf53d903ab">

              <tr>
                <td style="width: 21.25pt; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: bold;">
                  <div style="font-weight: normal;">&#9642;</div>
                </td>
                <td style="width: auto; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="text-align: justify;">IperionX and Oak Ridge National Laboratory (&#8220;ORNL&#8221;) to collaborate on developing low-cost titanium alloys for additive manufacturing (3D printing) using IperionX&#8217;s titanium metal powders</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcdc1ae030eec489ab52f1ab037641bf2">

              <tr>
                <td style="width: 21.25pt; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div>&#9642;</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify;"><font style="font-weight: normal; font-style: normal; color: rgb(111, 114, 113);">A U.S. Department of Energy (&#8220;DOE&#8221;) approved User Agreement has been executed to advance work between ORNL and IperionX at
                      DOE&#8217;s Manufacturing Demonstration Facility (&#8220;MDF&#8221;) at ORNL, a 110,000 sq. ft. user facility that is the nation&#8217;s only large-scale open-access facility for demonstrating R&amp;D manufacturing technologies and optimizing critical
                      processes (<u>link</u>)</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z740053b31cd2420790cd836e598b2b66">

              <tr>
                <td style="width: 21.25pt; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div>&#9642;</div>
                </td>
                <td style="width: auto; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="text-align: justify;">Key objectives of the User Agreement include:</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc7796855be864f6cb6c042fd123fab36">

              <tr>
                <td style="width: 36pt; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="margin-left: 18pt;">o</div>
                </td>
                <td style="width: auto; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="text-align: justify;">Evaluation &amp; characterization of titanium spherical powders produced through IperionX's technologies for use in additive manufacturing / 3D printing, including opportunities to use titanium powders to
                    parts which currently rely on other metals, including stainless steel and aluminum</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc0055002988c42b586725fdc1b75742b">

              <tr>
                <td style="width: 36pt; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="margin-left: 18pt;">o</div>
                </td>
                <td style="width: auto; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="text-align: justify;">Demonstration that pressed and sintered parts produced using IperionX&#8217;s titanium powders have equivalent or better characteristics to parts produced using industry standard titanium powders</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf0cbc976c0e6423babb2124e38921baa">

              <tr>
                <td style="width: 21.25pt; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div>&#9642;</div>
                </td>
                <td style="width: auto; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="text-align: justify;">The User Agreement will complement an ongoing project to qualify and demonstrate the performance of IperionX&#8217;s titanium powder for additively manufactured aerospace parts, supporting a project with the
                    U.S. Navy to test titanium flight critical metal replacement components for the U.S. Department of Defense (&#8220;DoD&#8221;)</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div style="text-align: justify; font-style: normal; font-weight: normal; color: rgb(146, 146, 146);"><font style="font-weight: bold; color: rgb(111, 114, 113);">IperionX Limited (&#8220;IperionX&#8221; or &#8220;Company&#8221;) (NASDAQ: IPX, ASX: IPX)</font><font style="color: rgb(111, 114, 113);"> is pleased to announce that the U.S. Department of Energy (&#8220;DOE&#8221;) has approved a technical collaboration between IperionX and Oak Ridge National Laboratory to advance the application of low cost alloys
            utilizing spherical powder produced through IperionX&#8217;s titanium technologies.</font></div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div style="text-align: justify;"><font style="font-weight: normal; font-style: normal; color: rgb(111, 114, 113);">The User Agreement has been executed to advance work between ORNL and IperionX at DOE&#8217;s Manufacturing Demonstration Facility (&#8220;MDF&#8221;)
            at ORNL. The MDF is a 110,000 sq. ft. facility that is the nation&#8217;s only large-scale open-access user facility for rapidly demonstrating R&amp;D manufacturing technologies and optimizing critical processes (</font><font style="color: rgb(111, 114, 113);"><u><font style="font-style: normal; font-weight: normal;">link</font></u></font><font style="font-weight: normal; font-style: normal; color: rgb(111, 114, 113);">). Key objectives of the User Agreement include:</font></div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3d3acd6e89714d46ac9aa9fe7188debc">

              <tr>
                <td style="width: 35.7pt; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="margin-left: 17.85pt;">&#9642;</div>
                </td>
                <td style="width: auto; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="text-align: justify;">Evaluation &amp; characterization of spherical titanium powders produced through IperionX's technologies for use in additive manufacturing / 3D printing, including opportunities to use titanium powders to
                    manufacture parts which currently rely on other metals, including stainless steel and aluminum</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5ee557c6b6c74f789585cbd7ecc953f4">

              <tr>
                <td style="width: 35.7pt; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="margin-left: 17.85pt;">&#9642;</div>
                </td>
                <td style="width: auto; vertical-align: top; font-style: normal; color: rgb(111, 114, 113); font-weight: normal;">
                  <div style="text-align: justify;">Demonstration that pressed and sintered parts produced using IperionX&#8217;s titanium powders have equivalent or better characteristics to parts produced using industry standard titanium powders</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div style="text-align: justify; font-style: normal; font-weight: normal; color: rgb(111, 114, 113);">ORNL has been at the forefront of research and development relating to low-cost titanium powder technologies including applications in the
          automotive, defense and aerospace industries.</div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div style="text-align: justify; font-style: normal; font-weight: normal; color: rgb(111, 114, 113);">As a focus of the collaboration, initially, pressed and sintered parts will be produced and tested at the MDF with the aim of validating that the
          components fabricated with commercially pure titanium or Ti-6Al-4V alloy produced by IperionX meet the characteristics for light-weighting for the transportation sector, including heavy trucks, aircraft components and other transportation
          applications where titanium has an advantage over currently used metals such as steel and aluminum.</div>
        <div style="font-style: normal; color: rgb(111, 114, 113); font-weight: normal;"><br>
        </div>
        <div style="text-align: justify; font-style: normal; font-weight: normal; color: rgb(111, 114, 113);">The User Agreement will complement IperionX&#8217;s ongoing project to qualify and demonstrate the performance of its U.S. produced titanium powder for
          additively manufactured aerospace parts, supporting a project with the U.S. Navy to test titanium flight critical metal replacement components for the U.S. Department of Defense.</div>
        <div style="text-align: justify; font-style: italic; font-weight: bold;"><font style="font-style: normal; color: rgb(182, 182, 182);"> </font><br>
        </div>
        <div style="text-align: justify; font-style: italic; font-weight: bold;"><font style="font-style: normal; color: rgb(182, 182, 182);"> </font>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td colspan="1" rowspan="3" style="width: 13%;"><img src="image00003.jpg"></td>
                <td style="width: 29%; text-align: left; vertical-align: bottom;">
                  <div style="color: rgb(0, 37, 84); font-size: 8pt;">
                    <div style="color: rgb(0, 37, 84); font-size: 10pt; font-weight: bold;">Corporate Office</div>
                  </div>
                </td>
                <td colspan="1" style="width: 29%; text-align: left; vertical-align: bottom;">
                  <div style="color: rgb(0, 37, 84);"><font style="font-weight: bold;">Tennessee Office</font><br>
                  </div>
                </td>
                <td colspan="1" style="width: 29%; text-align: left; vertical-align: bottom;">
                  <div><font style="font-weight: bold; color: rgb(0, 37, 84);">Salt Lake City Office </font><br>
                  </div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 29%; text-align: left; vertical-align: middle;">&#160;</td>
                <td colspan="1" rowspan="1" style="width: 29%; text-align: left; vertical-align: middle;">&#160;</td>
                <td colspan="1" rowspan="1" style="width: 29%; text-align: left; vertical-align: middle;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 29%; text-align: left; vertical-align: top;">
                  <div style="color: rgb(111, 114, 113); font-size: 8pt; font-style: italic;">
                    <div style="font-style: normal;">129 W Trade St, Suite 1405 Charlotte, NC 28202<br>
                    </div>
                  </div>
                </td>
                <td colspan="1" style="width: 29%; text-align: left; vertical-align: top;">
                  <div style="font-size: 8pt; color: rgb(111, 114, 113);">279 West Main St, Camden, TN 38320 <br>
                  </div>
                </td>
                <td colspan="1" style="width: 29%; text-align: left; vertical-align: top;">
                  <div style="font-size: 8pt; color: rgb(111, 114, 113);">1782 W 2300 S, West Valley City, UT 84119 <br>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-align: justify; font-style: italic; font-weight: bold;"><font style="font-style: normal; color: rgb(182, 182, 182);"> </font><br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div>
          <div id="DSPFPageHeader">
            <div style="color: #002554; font-style: italic; font-weight: bold;">Anastasios (Taso) Arima, IperionX&#8217;s Managing Director and CEO said: <font style="color: rgb(111, 114, 113); font-weight: normal;">&#8220;We are extremely pleased to be working with
                ORNL. The laboratory is an ideal partner for IperionX, with expertise in additive manufacturing, along with a strong interest in identifying new powder feedstocks that lower costs and increase energy efficiency, particularly in
                transportation.</font></div>
          </div>
          <div style="color: rgb(111, 114, 113); font-weight: normal;"><br>
          </div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic; font-weight: normal;">ORNL brings a knowledge base from numerous collaborations with advanced manufacturing companies, such as partnering in Volkswagen&#8217;s first U.S.
            innovation hub in Tennessee to develop lighter vehicle components from composite materials and electrify vehicles, its recent work with NASA which resulted in a 3D printed thermal protection shield traveling to the International Space Station,
            or its 3D printing work with Boeing&#8217;s 777x.</div>
          <div style="color: rgb(111, 114, 113); font-weight: normal;"><br>
          </div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic; font-weight: normal;">Both organizations share Tennessee roots, and we look forward to progressing the User Agreement and establishing a strong relationship between
            IperionX and ORNL.&#8221;</div>
          <div style="color: rgb(111, 114, 113); font-weight: normal; font-style: normal;"><br>
          </div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: normal; font-weight: normal;">This announcement has been authorized for release by the CEO and Managing Director.</div>
          <div style="color: rgb(111, 114, 113); font-weight: normal; font-style: normal;"><br>
          </div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: normal; font-weight: normal;">For further information and enquiries please contact:</div>
          <div style="color: rgb(111, 114, 113); font-weight: normal; font-style: normal;"><br>
          </div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: normal; font-weight: bold;">info@iperionx.com</div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: normal; font-weight: bold;">+1 980 237 8900</div>
          <div style="color: rgb(111, 114, 113); font-weight: normal; font-style: normal;"><br>
          </div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-weight: normal; font-style: normal;"><u>www.iperionx.com</u></div>
          <div style="color: rgb(111, 114, 113); font-weight: normal; font-style: normal;"><br>
          </div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: normal; font-weight: bold;">About IperionX</div>
          <div style="color: rgb(111, 114, 113); font-weight: normal; font-style: normal;"><br>
          </div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: normal; font-weight: normal;">IperionX&#8217;s mission is to be the leading developer of low carbon, sustainable, critical material supply chains focused on advanced industries
            including space, aerospace, electric vehicles and 3D printing. IperionX&#8217;s breakthrough titanium technologies have the potential to produce titanium products which are sustainable, 100% recyclable, low carbon intensity and at product qualities
            which exceed current industry standards. The Company also holds a 100% interest in the Titan Project, located in Tennessee, U.S., a very large titanium resource in North America which is also rich in rare earth minerals.</div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic; font-weight: bold;"><font style="font-weight: normal;"> </font><br>
          </div>
          <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic; font-weight: bold;"> <br>
          </div>
          <div style="text-align: justify; color: rgb(146, 146, 146); font-style: italic; font-weight: bold;"> <br>
          </div>
          <table cellspacing="0" cellpadding="4" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf0856836f461491b805d92d83762f60c">

              <tr>
                <td style="width: 100%; vertical-align: top; background-color: rgb(217, 217, 217); border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                  <div style="text-align: justify; color: rgb(111, 114, 113); font-size: 8pt; font-style: italic; font-weight: bold;">Forward Looking Statements</div>
                  <div>
                    <div>&#160;</div>
                    <div style="text-align: justify; color: #6F7271; font-size: 8pt; font-style: italic;">Information included in this release constitutes forward-looking statements. Often, but not always, forward looking statements can generally be
                      identified by the use of forward-looking words such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;continue&#8221;, and &#8220;guidance&#8221;, or other similar words and may include, without limitation, statements regarding
                      plans, strategies and objectives of management, anticipated production or construction commencement dates and expected costs or production outputs.</div>
                    <div style="text-align: justify; color: #6F7271; font-size: 8pt; font-style: italic;"> <br>
                    </div>
                    <div style="text-align: justify; color: #6F7271; font-size: 8pt; font-style: italic;">Forward looking statements inherently involve known and unknown risks, uncertainties and other factors that may cause the Company&#8217;s actual results,
                      performance, and achievements to differ materially from any future results, performance, or achievements. Relevant factors may include, but are not limited to, changes in commodity prices, foreign exchange fluctuations and general
                      economic conditions, increased costs and demand for production inputs, the speculative nature of exploration and project development, including the risks of obtaining necessary licenses and permits and diminishing quantities or grades
                      of reserves, the Company&#8217;s ability to comply with the relevant contractual terms to access the technologies, commercially scale its closed-loop titanium production processes, or protect its intellectual property rights, political and
                      social risks, changes to the regulatory framework within which the Company operates or may in the future operate, environmental conditions including extreme weather conditions, recruitment and retention of personnel, industrial
                      relations issues and litigation.</div>
                    <div style="text-align: justify; color: #6F7271; font-size: 8pt; font-style: italic;"> <br>
                    </div>
                    <div style="text-align: justify; color: #6F7271; font-size: 8pt; font-style: italic;">Forward looking statements are based on the Company and its management&#8217;s good faith assumptions relating to the financial, market, regulatory and
                      other relevant environments that will exist and affect the Company&#8217;s business and operations in the future. The Company does not give any assurance that the assumptions on which forward looking statements are based will prove to be
                      correct, or that the Company&#8217;s business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company&#8217;s control.</div>
                    <div>&#160;</div>
                  </div>
                  <div style="text-align: justify; color: rgb(111, 114, 113); font-size: 8pt; font-style: italic; font-weight: normal;">There may be other factors that could cause actual results, performance, achievements, or events not to be as
                    anticipated, estimated or intended, and many events are beyond the reasonable control of the Company. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Forward looking statements in these
                    materials speak only at the date of issue. Subject to any continuing obligations under applicable law or any relevant stock exchange listing rules, in providing this information the Company does not undertake any obligation to publicly
                    update or revise any of the forward-looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.</div>
                </td>
              </tr>

          </table>
          <br>
        </div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
        <div><br>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  . )\# 2(  A$! Q$!_\0
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MP=\0W&O>));!+.Y:VMO$'D$,T8*X;;P223M]?F]1FO4?^$%\)?\ 0L:'_P"
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A>U<'-"E4BL9KMOKZ=[KI;H]7S?$=%G.+]E_7]?U;8__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  Z &$# 2(  A$! Q$!_\0
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)U"BBBO?.,__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
